EMA Authorised: Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) (tenofovir disoproxil) — Viatris Limited

View source ↗

Summary

EMA authorised a new medicinal product containing tenofovir disoproxil for HIV infections, marketed as Tenofovir disoproxil Viatris by Viatris Limited (formerly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir disoproxil Viatris (tenofovir disoproxil)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 05/09/2025